Unknown

Dataset Information

0

Bioinformatic Analyses and Experimental Verification Reveal that High FSTL3 Expression Promotes EMT via Fibronectin-1/α5β1 Interaction in Colorectal Cancer.


ABSTRACT: Background: Colorectal cancer (CRC) is a typical cancer prevalent worldwide. Despite the conventional treatments, CRC has a poor prognosis due to relapse and metastasis. Moreover, there is a dearth of sensitive biomarkers for predicting prognosis in CRC. Methods: This study used a bioinformatics approach combining validation experiments to examine the value of follistatin-like 3 (FSTL3) as a prognostic predictor and therapeutic target in CRC. Results: FSTL3 was remarkably upregulated in the CRC samples. FSTL3 overexpression was significantly associated with a poor prognosis. FSTL3 was found to activate the epithelial-mesenchymal transition by promoting the binding of FN1 to α5β1. FSTL3 expression was also positively correlated with the abundance of the potent immunosuppressors, M2 macrophages. Conclusion: FSTL3 overexpression affects CRC prognosis and thus, FSTL3 can be a prognostic biomarker and therapeutic target with potential applications in CRC.

SUBMITTER: Liu Y 

PROVIDER: S-EPMC8652210 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4951027 | biostudies-literature
| S-EPMC8806911 | biostudies-literature
| S-EPMC5541835 | biostudies-literature
| S-EPMC6209122 | biostudies-literature
| S-EPMC8515505 | biostudies-literature
| S-EPMC6207534 | biostudies-literature
| S-EPMC1874648 | biostudies-literature
| S-EPMC10420078 | biostudies-literature
2022-08-09 | PXD031508 | Pride
| S-EPMC3317794 | biostudies-literature